sovren.media

The South Korea anxiety disorder and depression market is expected to grow at a CAGR of 3.8% between 2024 and 2032. UNICEF and BTS’ collaboration for LOVE MYSELF CAMPAIGN, along with COVID-19 and lockdown significantly propel the growth if the industry in South Korea. For more Visit https://www.expertmarketresearch.com/reports/south-korea-anxiety-disorder-and-depression-market

South Korea Anxiety Disorder and Depression Market Report and Forecast 2024-2032

Based on Drug class the South Korea anxiety disorder and depression market is segmented into antidepressant drugs, therapy and devices, and indication. The antidepressant segment is further classified into Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs).